Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs

Virology

Volumn 265, Issue 2, 1999, Pages 252-263

  Ui, Masahiro ^a   Kuwata, Takeo ^a   Igarashi, Tatsuhiko ^a   Ibuki, Kentaro ^a   Miyazaki, Yasuyuki ^a   Kozyrev, Iouly L ^a   Enose, Yoshimi ^a   Shimada, Toshihide ^a   Uesaka, Hiromi ^a,b   Yamamoto, Hiroshi ^b   Miura, Tomoyuki ^a   Hayami, Masanori ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE DELETION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; MACACA; MALE; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS; VACCINATION; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; RNA VIRUSES; SIMIAE; SIMIAN VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 17144451906     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0049     Document Type: Article

References (76)

1. Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:1986;284-291.
2. Almond N., Kent K., Cranage M., Rud E., Clarke B., Stott E. J. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet. 345:1995;1342-1344.
3. Almond N. M., Heeney J. L. AIDS vaccine development in primate models. AIDS. 12:1998;S133-S140.
4. Baba T. W., Jeong Y. S., Pennick D., Bronson R., Greene M. F., Ruprecht R. M. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science. 267:1995;1820-1825.
5. Baba T. W., Liska V., Khimani A. H., Ray N. B., Dailey P. J., Penninck D., Bronson R., Greene M. F., McClure H. M., Martin L. N., Ruprecht R. M. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nature Med. 5:1999;194-203.
6. Bogers W. M., Niphuis H., ten Haaft P., Laman J. D., Koornstra W., Heeney J. L. Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge. AIDS. 9:1995;F13-F18.
7. Carpio E., Duarte C., Hinkula J., Broliden P. A., Rosen J., Campal A., Gavilondo J., Wahren B., Jondal M. Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2. AIDS. Res. Hum. Retroviruses. 7:1991;97-101.
8. MMWR Morb. Mortal Wkly. Rep. 46:1997;129-131.
9. Clapham P. R., Weiss R. A., Dalgleish A. G., Exley M., Whitby D., Hogg N. Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: Receptor modulation and differentiation induced by phorbol ester. Virology. 158:1987;44-51.
10. Clements J. E., Montelaro R. C., Zink M. C., Amedee A. M., Miller S., Trichel A. M., Jagerski B., Hauer D., Martin L. N., Bohm R. P., Murphey-Corb M. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69:1995;2737-2744.
11. Connor R. I., Montefiori D. C., Binley J. M., Moore J. P., Bonhoeffer S., Gettie A., Fenamore E. A., Sheridan K. E., Ho D. D., Dailey P. J., Marx P. A. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J. Virol. 72:1998;7501-7509.
12. Daniel M. D., Kirchhoff F., Czajak S. C., Sehgal P. K., Desrosiers R. C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science. 258:1992;1938-1941.
13. Deacon N. J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D. J., McPhee D. A., Greenway A. L., Ellett A., Chatfield C., Lawson V. A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J. S., A. C., Dwyer D., Dowton D., Milles J. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 270:1995;988-991.
14. Desrosiers R. C. Prospects for live attenuated HIV. Nature Med. 4:1998;982.
15. Desrosiers R. C., Lifson J. D., Gibbs J. S., Czajak S. C., Howe A. Y., Arthur L. O., Johnson R. P. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72:1998;1431-1437.
16. Dittmer U., Brooks D. M., Hasenkrug K. J. Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection. Nature Med. 5:1999;189-193.
17. Dunn C. S., Hurtrel B., Beyer C., Gloeckler L., Ledger T. N., Moog C., Kieny M. P., Mehtali M., Schmitt D., Gut J. P., Kirn A., Aubertin A. M. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1. AIDS. Res. Hum. Retroviruses. 13:1997;913-922.
18. Fultz P. N., Srinivasan A., Greene C. R., Butler D., Swenson R. B., McClure H. M. Superinfection of a chimpanzee with a second strain of human immunodeficiency virus. J. Virol. 61:1987;4026-4029.
19. Gibbs C. J. Jr., Peters R., Gravell M., Johnson B. K., Jensen F. C., Carlo D. J., Salk J. Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzees. Proc. Natl. Acad. Sci. USA. 88:1991;3348-3352.
20. Gundlach B. R., Reiprich S., Sopper S., Means R. E., Dittmer U., Matz-Rensing K., Stahl-Hennig C., Uberla K. Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines. J. Virol. 72:1998;7846-7851.
21. Haga T., Kuwata T., Ui M., Igarashi T., Miyazaki Y., Hayami M. A new approach to AIDS research and prevention: The use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines. Microbiol. Immunol. 42:1998;245-251.
22. Hayami M., Igarashi T. SIV/HIV-1 chimeric viruses having HIV-1 env gene: A new animal model and a candidate for attenuated live vaccine. Leukemia. 11:1997;95-97.
23. Hayami M., Igarashi T., Kuwata T., Ui M., Haga T., Ami Y., Shinohara K., Honda M. Gene-mutated HIV-1/SIV chimeric viruses as AIDS live attenuated vaccines for potential human use. Leukemia. 13:1999;S42-S47.
24. Igarashi T., Ami Y., Yamamoto H., Shibata R., Kuwata T., Mukai R., Shinohara K., Komatsu T., Adachi A., Hayami M. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: A potential candidate live-attenuated human AIDS vaccine. J. Gen. Virol. 78:1997;985-989.
25. Igarashi T., Kuwata T., Yamamoto H., Moriyama H., Ui M., Miyazaki Y., Hayami M. Infectivity and immunogenicity of SIVmac/HIV-1 chimeric viruses (SHIVs) with deletions in two or three genes (vpr, nef and vpx). Microbiol. Immunol. 42:1998;71-74.
26. Igarashi T., Shibata R., Hasebe F., Ami Y., Shinohara K., Komatsu T., Stahl-Hennig C., Petry H., Hunsmann G., Kuwata T., Hayami M. Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys. AIDS. Res. Hum. Retroviruses. 10:1994;1021-1029.
27. Iuliano R., Forastieri G., Brizzi M., Mecocci L., Mazzotta F., Ceccherini-Nelli L. Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 14:1997;408-414.
28. Joag S. V., Li Z., Foresman L., Pinson D. M., Raghavan R., Zhuge W., Adany I., Wang C., Jia F., Sheffer D., Ranchalis J., Watson A., Narayan O. Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques. AIDS. Res. Hum. Retroviruses. 13:1997;635-645.
29. Joag S. V., Liu Z. Q., Stephens E. B., Smith M. S., Kumar A., Li Z., Wang C., Sheffer D., Jia F., Foresman L., Adany I., Lifson J., McClure H. M., Narayan O. Oral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS. J. Virol. 72:1998;9069-9078.
30. Johnson R. P. Live attenuated AIDS vaccines: Hazards and hopes. Nature Med. 5:1999;154-155.
31. Johnson R. P., Desrosiers R. C. Protective immunity induced by live attenuated simian immunodeficiency virus. Curr. Opin. Immunol. 10:1998;436-443.
32. Karlsson G. B., Halloran M., Li J., Park I. W., Gomila R., Reimann K. A., Axthelm M. K., Iliff S. A., Letvin N. L., Sodroski J. Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys. J. Virol. 71:1997;4218-4225.
33. + T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J. Exp. Med. 188:1998;1159-1171.
34. Kestler H., Kodama T., Ringler D., Marthas M., Pedersen N., Lackner A., Regier D., Sehgal P., Daniel M., King N. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science. 248:1990;1109-1112.
35. Kestler H. W. D., Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 65:1991;651-662.
36. Khabbaz R. F., Heneine W., George J. R., Parekh B., Rowe T., Woods T., Switzer W. M., McClure H. M., Murphey-Corb M., Folks T. M. Brief report: Infection of a laboratory worker with simian immunodeficiency virus. N. Engl. J. Med. 330:1994;172-177.
37. Khabbaz R. F., Rowe T., Murphey-Corb M., Heneine W. M., Schable C. A., George J. R., Pau C. P., Parekh B. S., Lairmore M. D., Curran J. W. Simian immunodeficiency virus needlestick accident in a laboratory worker. Lancet. 340:1992;271-273.
38. Klinger J. M., Himathongkham S., Legg H., Luciw P. A., Barnett S. W. Infection of baboons with a simian immunodeficiency virus/HIV-1 chimeric virus constructed with an HIV-1 Thai subtype E envelope. AIDS. 12:1998;849-857.
39. Kuwata T., Igarashi T., Ido E., Jin M., Mizuno A., Chen J., Hayami M. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. J. Gen. Virol. 76:1995;2181-2191.
40. Kuwata T., Shioda T., Igarashi T., Ido E., Ibuki K., Enose Y., Stahl-Hennig C., Hunsmann G., Miura T., Hayami M. Chimeric viruses between SIVmac and various HIV-1 isolates have biological properties that are similar to those of the parental HIV-1. AIDS. 10:1996;1331-1337.
41. Lang S. M., Weeger M., Stahl-Hennig C., Coulibaly C., Hunsmann G., Muller J., Muller-Hermelink H., Fuchs D., Wachter H., Daniel M. M. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 67:1993;902-912.
42. + T helper cells from simian/human immunodeficiency virus-infected rhesus monkeys recognize epitopes restricted by MHC class II DRB1*0406 and DRB*W201 molecules. J. Immunol. 159:1997;2049-2057.
43. Letvin N. L. Progress in the development of an HIV-1 vaccine. Science. 280:1998;1875-1880.
44. Letvin N. L., Li J., Halloran M., Cranage M. P., Rud E. W., Sodroski J. Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus. J. Virol. 69:1995;4569-4571.
45. Li J., Lord C. I., Haseltine W., Letvin N. L., Sodroski J. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J. Acquired Immune Defic. Syndr. 5:1992;639-646.
46. Lohman B. L., McChesney M. B., Miller C. J., McGowan E., Joye S. M., Van Rompay K. K., Reay E., Antipa L., Pedersen N. C., Marthas M. L. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68:1994;7021-7029.
47. Luciw P. A., Pratt-Lowe E., Shaw K. E., Levy J. A., Cheng-Mayer C. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc. Natl. Acad. Sci. USA. 92:1995;7490-7494.
48. Marthas M. L., Sutjipto S., Higgins J., Lohman B., Torten J., Luciw P. A., Marx P. A., Pedersen N. C. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J. Virol. 64:1990;3694-3700.
49. Mellado M., Rodriguez-Frade J. M., Vila-Coro A. J., de Ana A. M., Martinez A. C. Chemokine control of HIV-1 infection. Nature. 400:1999;723-724.
50. Miller C. J., McChesney M. B., Lu X., Dailey P. J., Chutkowski C., Lu D., Brosio P., Roberts B., Lu Y. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J. Virol. 71:1997;1911-1921.
51. Montefiori D. C., Reimann K. A., Wyand M. S., Manson K., Lewis M. G., Collman R. G., Sodroski J. G., Bolognesi D. P., Letvin N. L. Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1. J. Virol. 72:1998;3427-3431.
52. Nara P. L., Robey W. G., Arthur L. O., Asher D. M., Wolff A. V., Gibbs C. J. Jr., Gajdusek D. C., Fischinger P. J. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J. Virol. 61:1987;3173-3180.
53. Novembre F. J., Saucier M., Anderson D. C., Klumpp S. A., O'Neil S. P., Brown C. R. II, Hart C. E., Guenthner P. C., Swenson R. B., McClure H. M. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J. Virol. 71:1997;4086-4091.
54. Otsyula M. G., Miller C. J., Tarantal A. F., Marthas M. L., Greene T. P., Collins J. R., van Rompay K. K., McChesney M. B. Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251. Virology. 222:1996;275-278.
55. Pantaleo G., Graziosi C., Demarest J. F., Butini L., Montroni M., Fox C. H., Orenstein J. M., Kotler D. P., Fauci A. S. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 362:1993;355-358.
56. Pantaleo G., Graziosi C., Demarest J. F., Cohen O. J., Vaccarezza M., Gantt K., Muro-Cacho C., Fauci A. S. Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol. Rev. 140:1994;105-130.
57. Pantaleo G., Menzo S., Vaccarezza M., Graziosi C., Cohen O. J., Demarest J. F., Montefiori D., Orenstein J. M., Fox C., Schrager L. K., Margolick J. B., Buchbinder S., Giorgi J. V., Fauci A. S. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:1995;209-216.
58. Petry H., Dittmer U., Stahl-Hennig C., Coulibaly C., Makoschey B., Fuchs D., Wachter H., Tolle T., Morys-Wortmann C., Kaup F. J., Jurkiewicz E., Luke W., Hunsmann G. Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection. J. Virol. 69:1995;1564-1574.
59. Putkonen P., Walther L., Zhang Y. J., Li S. L., Nilsson C., Albert J., Biberfeld P., Thorstensson R., Biberfeld G. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nature Med. 1:1995;914-918.
60. Quesada-Rolander M., Makitalo B., Thorstensson R., Zhang Y. J., Castanos-Velez E., Biberfeld G., Putkonen P. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. AIDS Res. Hum. Retroviruses. 12:1996;993-999.
61. Reimann K. A., Li J. T., Veazey R., Halloran M., Park I. W., Karlsson G. B., Sodroski J., Letvin N. L. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70:1996a;6922-6928.
62. Reimann K. A., Li J. T., Voss G., Lekutis C., Tenner-Racz K., Racz P., Lin W., Montefiori D. C., Lee-Parritz D. E., Lu Y., Collman R. G., Sodroski J., Letvin N. L. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J. Virol. 70:1996b;3198-3206.
63. Robinson H. L., Montefiori D. C., Johnson R. P., Manson K. H., Kalish M. L., Lifson J. D., Rizvi T. A., Lu S., Hu S. L., Mazzara G. P., Panicali D. L., Herndon J. G., Glickman R., Candido M. A., Lydy S. L., Wyand M. S., McClure H. M. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nature Med. 5:1999;526-534.
64. Sakuragi S., Shibata R., Mukai R., Komatsu T., Fukasawa M., Sakai H., Sakuragi J., Kawamura M., Ibuki K., Hayami M. Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus. J. Gen. Virol. 73:1992;2983-2987.
65. Shibata R., Kawamura M., Sakai H., Hayami M., Ishimoto A., Adachi A. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65:1991;3514-3520.
66. Shibata R., Seimon C., Cho M. W., Arthur L. O., Nigida S. M. Jr., Matthews T., Sawyer L. A., Schultz A., Murthy K. K., Israel Z., Javadian A., Frost P., Kennedy R. C., Lane H. C., Martin M. A. Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J. Virol. 70:1996;4361-4369.
67. Shibata R., Seimon C., Czajak S. C., Desrosiers R. C., Martin M. A. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J. Virol. 71:1997;8141-8148.
68. Stahl-Hennig C., Dittmer U., Nisslein T., Petry H., Jurkiewicz E., Fuchs D., Wachter H., Matz-Rensing K., Kuhn E. M., Kaup F. J., Rud E. W., Hunsmann G. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. J. Gen. Virol. 77:1996;2969-2981.
69. Steger K. K., Dykhuizen M., Mitchen J. L., Hinds P. W., Preuninger B. L., Wallace M., Thomson J., Montefiori D. C., Lu Y., Pauza C. D. CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques. J. Virol. 72:1998;1600-1605.
70. Stephens E. B., Joag S. V., Atkinson B., Sahni M., Li Z., Foresman L., Adany I., Narayan O. Infected macaques that controlled replication of SIVmac or nonpathogenic SHIV developed sterilizing resistance against pathogenic SHIV(KU-1). Virology. 234:1997;328-339.
71. Suryanarayana K., Wiltrout T. A., Vasquez G. M., Hirsch V. M., Lifson J. D. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS. Res. Hum. Retroviruses. 14:1998;183-189.
72. Ten Haaft P., Verstrepen B., Uberla K., Rosenwirth B., Heeney J. A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J. Virol. 72:1998;10281-10285.
73. Van Rompay K. K., Otsyula M. G., Tarara R. P., Canfield D. R., Berardi C. J., McChesney M. B., Marthas M. L. Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection. J. Infect. Dis. 173:1996;1327-1335.
74. Voss G., Letvin N. L. Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys. J. Virol. 70:1996;7335-7340.
75. Watson A., Ranchalis J., Travis B., McClure J., Sutton W., Johnson P. R., Hu S. L., Haigwood N. L. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J. Virol. 71:1997;284-290.
76. Yamamoto H., Miller M. D., Tsubota H., Watkins D. I., Mazzara G. P., Stallard V., Panicali D. L., Aldovini A., Young R. A., Letvin N. L. Studies of cloned simian immunodeficiency virus-specific T lymphocytes: Gag-specific cytotoxic T lymphocytes exhibit a restricted epitope specificity. J. Immunol. 144:1990;3385-3391.